OR WAIT null SECS
January 26, 2026
Article
MannKind Therapeutics has announced new starting dose recommendations for patients with type 1 diabetes switching from injected or insulin pump mealtime therapy.
January 21, 2026
Video
This segment of Diabetes Dialogue spotlights the FDA clearance of the MiniMed Go and its collaborative capacity with various other devices.
January 20, 2026
This segment of Diabetes Dialogue spotlights the recent announcement of a partnership between Diabeloop and Sequel Med Tech.
January 19, 2026
An audio recap of the top 5 stories in healthcare news from the week of 01/04-01/10.
January 16, 2026
Podcast
Diana Isaacs, PharmD, and Natalie Bellini, DNP, review tech updates from Sequel Med Tech, Diabeloop, and Medtronic.
January 15, 2026
Diana Isaacs, PharmD, and Natalie Bellini, DNP, are joined by Susan Weiner, MS, to discuss the recently released US Dietary Guidelines.
January 13, 2026
January 12, 2026
According to an announcement by parent company Medtronic, the MiniMed Go app is expected to launch in the spring of 2026.
January 07, 2026
The Q4 recap for endocrinology spotlights major FDA decisions, updates to diabetes care standards, and key clinical trial updates.
January 05, 2026
Data from the ongoing phase 4 PETITE-T1D study, highlighting the substantially reduced progression to stage 3 T1D, headline the application.
